Staff Contact: Sarah Willson or Alison Williams
The Institute for Safe Medication Practices is aware of an extremely hazardous packaging error involving certain cisatracurium products from Meitheal Pharmaceuticals. While the outer carton identifies the vials inside as cisatracurium, the vials contained in the carton are labeled phenylephrine injection. The vials actually contain cisatracurium and have caps appropriate for a paralyzing agent. However, this cap warning may not be noticed since the vial is labeled phenylephrine.
Due to the nature of this situation and the potential for death if these vials are used as phenylephrine injection in patients who are not intubated and ventilated, we urge facilities to immediately examine all cartons of cisatracurium from Meitheal Pharmaceuticals for this serious packaging error. The possibility that any of these vials were actually distributed also should be considered. ISMP has confirmed that both the U.S. Food and Drug Administration and the manufacturer are aware of this situation and that a recall is imminent.